# A Study in Patients With Diabetes Mellitus Type II of the Effect on Albuminuria of 24 Week Treatment With Valsartan, Benazepril, and Valsartan+Benazepril

> **NCT00171119** · PHASE4 · TERMINATED · sponsor: **Novartis Pharmaceuticals** · enrollment: 81 (actual)

## Conditions studied

- Hypertension
- Diabetic Nephropathy

## Interventions

- **DRUG:** valsartan

## Key facts

- **NCT ID:** NCT00171119
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2004-01
- **Primary completion:** 2005-03
- **Final completion:** —
- **Target enrollment:** 81 (ACTUAL)
- **Last updated:** 2008-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00171119

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00171119, "A Study in Patients With Diabetes Mellitus Type II of the Effect on Albuminuria of 24 Week Treatment With Valsartan, Benazepril, and Valsartan+Benazepril". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00171119. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*